Stevenb Binder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem...

MannKind (NASDAQ:MNKD – Get Free Report) had its price target upped by investment analysts at Cantor Fitzgerald from $6.50 to $7.50 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 41.78% from […]

MannKind (NASDAQ:MNKD – Get Free Report) had its target price upped by equities research analysts at Cantor Fitzgerald from $6.50 to $7.50 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 41.78% from […]

Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) hit a new 52-week high on Wednesday after Cantor Fitzgerald raised their price target on the stock from $6.50 to $7.50. Cantor Fitzgerald currently has an overweight rating on the stock. MannKind traded as high as $5.75 and last traded at $5.64, with a volume of […]

Raymond James & Associates grew its holdings in MannKind Co. (NASDAQ:MNKD – Get Rating) by 80.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 619,267 shares of the biopharmaceutical company’s stock after acquiring an additional 276,588 shares during the period. Raymond James & Associates’ holdings in MannKind were worth $3,264,000 at the end […]